1. Home
  2. IMMX vs CCSI Comparison

IMMX vs CCSI Comparison

Compare IMMX & CCSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immix Biopharma Inc.

IMMX

Immix Biopharma Inc.

N/A

Current Price

$9.44

Market Cap

784.8M

Sector

Health Care

ML Signal

N/A

Logo Consensus Cloud Solutions Inc.

CCSI

Consensus Cloud Solutions Inc.

N/A

Current Price

$36.60

Market Cap

648.0M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
IMMX
CCSI
Founded
2014
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
784.8M
648.0M
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
IMMX
CCSI
Price
$9.44
$36.60
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
4
Target Price
$24.30
★ $42.25
AVG Volume (30 Days)
★ 1.4M
102.3K
Earning Date
11-06-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ 2.72
Revenue
N/A
★ $349,696,000.00
Revenue This Year
N/A
$3.01
Revenue Next Year
N/A
$3.66
P/E Ratio
★ N/A
$13.46
Revenue Growth
★ N/A
N/A
52 Week Low
$2.31
$20.20
52 Week High
$15.10
$41.40

Technical Indicators

Market Signals
Indicator
IMMX
CCSI
Relative Strength Index (RSI) 33.13 53.44
Support Level $7.96 $32.99
Resistance Level $10.40 $39.20
Average True Range (ATR) 0.76 1.15
MACD -0.23 0.19
Stochastic Oscillator 11.55 90.24

Price Performance

Historical Comparison
IMMX
CCSI

About IMMX Immix Biopharma Inc.

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.

About CCSI Consensus Cloud Solutions Inc.

Consensus Cloud Solutions Inc is a provider of secure information delivery services with a scalable Software-as-a-Service SaaS platform. It is engaged in the fax cloud business. The company's offerings include communication, data extraction, and digital signature solutions that enable users to securely access, exchange, and manage information across organizational and geographic boundaries. It serves multiple industry verticals, including healthcare, government, financial services, legal, and education. Geographically, the company operates in the United States, Canada, Ireland, and other countries. It derives the maximum revenue from the United States.

Share on Social Networks: